臨床試驗

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT：NCT06388707 · RECRUITING

NCT IDNCT06388707

狀態RECRUITING

開始日期2024-09-13

完成時間2027-10-31

SponsorNaviFUS Corporation (INDUSTRY)

First posted2024-04-29

Last updated2026-09-15

簡要摘要

This will be a prospective, open-label, single-arm, multi-center, pilot study to evaluate the safety, tolerability, and preliminary efficacy of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant unilateral or bilateral temporal lobe epilepsy (DR-TLE).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。